Year: 2016
Type: review
Study design: Study Protocol
Abstract: BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for the Management of Allergic Rhinoconjunctivitis. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in the management of allergic rhinoconjunctivitis. METHODS: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised. CONCLUSION: The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.
Authors: Sangeeta Dhami, Ulugbek Nurmatov, Graham Roberts, Oliver Pfaar, Antonella Muraro, Ignacio J. Ansotegui, Moises Calderon, Cemal Cingi, Pascal Demoly, Stephen Durham, Ronald Gerth van Wijk, Susanne Halken, Eckard Hamelmann, Peter Hellings, Lars Jacobsen, Edward Knol, Desiree Larenas Linnemann, Sandra Lin, Vivian Maggina, Hanneke Oude-Elberink, Giovanni Pajno, Ruby Panwankar, Elideanna Pastorello, Constantinos Pitsios, Giuseppina Rotiroti, Frans Timmermans, Olympia Tsilochristou, Eva-Maria Varga, Jamie Wilkinson, Andrew Williams, Margitta Worm, Luo Zhang, Aziz Sheikh
Institutions: University Hospital Southampton NHS Foundation Trust, NIHR Southampton Respiratory Biomedical Research Unit, St Mary's Hospital, David Hide Asthma and Allergy Research Centre, University of Southampton, Zentrum für Rhinologie und Allergologie, University Medical Centre Mannheim, Azienda Ospedale - Università Padova, Imperial College London, Eskişehir Osmangazi University, Inserm, Centre Hospitalier Universitaire de Montpellier, Erasmus MC, Odense University Hospital, Evangelisches Krankenhaus Bielefeld, Universitair Ziekenhuis Leuven, University Medical Center Utrecht, Hospital Médica Sur, Johns Hopkins University, Johns Hopkins Hospital, National and Kapodistrian University of Athens, Panagiotis & Aglaia Kyriakou Children's Hospital, University Medical Center Groningen, University of Groningen, University of Messina, Nippon Medical School, University of Milan, Harokopio University of Athens, Royal National Throat Nose and Ear Hospital, University College London, Charité – Universitätsmedizin Berlin, University of Graz, Medical University of Graz, European Union, Guy's and St Thomas' NHS Foundation Trust, University of Edinburgh
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,690
Funders: Johns Hopkins University, Regeneron Pharmaceuticals, University Hospital Southampton NHS Foundation Trust, National Institute for Health and Care Research, University of Southampton, Imperial College London, University College London, European Commission, University of Edinburgh, Institut National de la Santé et de la Recherche Médicale, Rijksuniversiteit Groningen, Odense Universitetshospital, Universitair Medisch Centrum Groningen, National and Kapodistrian University of Athens, Eskişehir Osmangazi Üniversitesi, Università degli Studi di Messina, Harokopio University, Regione del Veneto, European Academy of Allergy and Clinical Immunology, Allergopharma, Japan Society for the Promotion of Science
OpenAlex ID: W2303910125